These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17393109)

  • 1. Effect of antisense oligodeoxynucleotide of vascular endothelial growth factor C on lymphangiogenesis and angiogenesis of pancreatic cancer.
    Li K; Tao J; Li T; Yu Z; Yang Z; Wu H; Xiong J; Wang C
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):51-3. PubMed ID: 17393109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects on lymphangiogenesis and angiogenesis of lung cancer with antisense oligonucleotides of vascular endothelial growth factor C].
    Guo XF; Xu ZH; Chen YB; Xu ZH; Yang WT; Qian YY; Hu GQ
    Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):694-6. PubMed ID: 18956726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of VEGF-A/VEGF-C antisense oligodeoxynucleotide on angiogenesis, lymphangiogenesis, and tumor growth of breast cancer].
    Chen JS; Zhang YJ; Hu SE; Zhang HQ
    Ai Zheng; 2007 Sep; 26(9):972-6. PubMed ID: 17927855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of acetylsalicylic acid on tumor angiogenesis and lymphangiogenesis through inhibition of VEGF signaling in a murine sarcoma model.
    Zhang X; Wang Z; Wang Z; Zhang Y; Jia Q; Wu L; Zhang W
    Oncol Rep; 2013 May; 29(5):1907-13. PubMed ID: 23483185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis].
    Li K; Li MJ; He T; Zheng Z; Zheng XL; Qu BH; Wang Y; Duan X; Zheng YJ
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2386-90. PubMed ID: 20137690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foretinib inhibits angiogenesis, lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR-2/3 and TIE-2 signaling.
    Chen HM; Tsai CH; Hung WC
    Oncotarget; 2015 Jun; 6(17):14940-52. PubMed ID: 25909285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-C ShRNA inhibits pancreatic cancer growth and lymphangiogenesis in an orthotopic fluorescent nude mouse model.
    Shi Y; Tong M; Wu Y; Yang Z; Hoffman RM; Zhang Y; Tian Y; Qi M; Lin Y; Liu Y; Dai L; Sun Y; Wang Z
    Anticancer Res; 2013 Feb; 33(2):409-17. PubMed ID: 23393331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
    Wang Z; Lv J; Zhang T
    Oncol Rep; 2015 May; 33(5):2468-76. PubMed ID: 25778843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
    Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of vascular endothelial growth factor antisense oligodeoxynucleotides on angiogenesis in lymphoma of nude mice].
    Tong YJ; Zhang M; Zou P; Guo R; Yuan YH
    Ai Zheng; 2005 Jan; 24(1):62-6. PubMed ID: 15642202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer.
    Hotz HG; Hines OJ; Masood R; Hotz B; Foitzik T; Buhr HJ; Gill PS; Reber HA
    Surgery; 2005 Feb; 137(2):192-9. PubMed ID: 15674201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rosiglitazone on the growth and lymphangiogenesis of human gastric cancer transplanted in nude mice.
    Chen FZ; Mo XM; Wang QP; Li J; Zhang L
    Oncol Rep; 2013 Dec; 30(6):2705-12. PubMed ID: 24002492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase.
    Matsui J; Funahashi Y; Uenaka T; Watanabe T; Tsuruoka A; Asada M
    Clin Cancer Res; 2008 Sep; 14(17):5459-65. PubMed ID: 18765537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
    He XW; Yu X; Liu T; Yu SY; Chen DJ
    Chin Med J (Engl); 2008 Mar; 121(5):439-44. PubMed ID: 18364118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNAi-mediated gene silencing of vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of gastric cancer in vivo in mice.
    Yao J; Da M; Guo T; Duan Y; Zhang Y
    Tumour Biol; 2013 Jun; 34(3):1493-501. PubMed ID: 23475632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of VEGF antisense oligonucleotides combined with low molecular weight heparin on the growth and metastasis of mice Lewis lung cancer].
    Zhang YH; Wang C; Pang BS; Zhai ZG; Weng XZ
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):749-52. PubMed ID: 16681948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.